A Truncated Ah Receptor Blocks the Hypoxia and Estrogen Receptor Signaling Pathways: A Viable Approach for Breast Cancer Treatment
Authors:
- 8 November 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 3 (6) , 695-703
Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor which requires heterodimerization with the Ah receptor nuclear translocator (Arnt) for function. Arnt is also a dimerization partner of the hypoxia inducible factor 1α (HIF-1α) for the hypoxia signaling. Additionally, Arnt is found to be a potent coactivator of the estrogen receptor (ER) signaling. Thus we examined whether the presence of an increased amount of AhR may suppress both the HIF-1α and ER signaling pathways by sequestering Arnt. We tested our hypothesis using a human AhR construct CΔ553 which is capable of heterodimerizing with Arnt in the absence of a ligand. Transient transfection studies using a corresponding luciferase reporter plasmid in MCF-7 cells showed that CΔ553 effectively suppressed the AhR, HIF-1α, and ER signaling pathways. Reverse transcription/real-time QPCR data showed that CΔ553 blocked the up-regulation of the target genes controlled by AhR (CYP1A1), HIF-1α (VEGF, aldolase C, and LDH-A), and ER (GREB1, pS2, and c-myc) in MCF-7 cells. Since both HIF-1α and ER are highly active in the ER-positive breast cancer, CΔ553 has the potential to be developed as a protein drug to treat breast cancer by blocking these two signaling pathways. Keywords: Estrogen receptor; Ah receptor; Arnt; HIF-1α; GREB1; protein drugsKeywords
This publication has 53 references indexed in Scilit:
- Mature results from a randomized Phase II trial of cisplatin plus 5‐fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasCancer, 2006
- GREB1 is a critical regulator of hormone dependent breast cancer growthBreast Cancer Research and Treatment, 2005
- The HIF pathway as a therapeutic targetDrug Discovery Today, 2004
- O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1Journal of Applied Physiology, 2004
- Interactions between 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Hypoxia Signaling Pathways in Zebrafish: Hypoxia Decreases Responses to TCDD in Zebrafish EmbryosToxicological Sciences, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Identification of a Motif within the 5‘ Regulatory Region of pS2 Which Is Responsible for AP-1 Binding and TCDD-Mediated SuppressionBiochemistry, 1997
- Oxygen- and dioxin-regulated gene expression in mouse hepatoma cellsKidney International, 1997
- Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1996